Compugen Ltd.
CGENBiotechnology
$1.98−2.94%As of Oct 30vs prior close
- Market cap
- $187.6M
- P/E (TTM)
- 5.2×
- From 52W high
- −36.13%
- EPS (YE25)
- $0.38
- Revenue (YE25)
- $72.8M
- Net margin
- 48.57%
- Dividend yield
- 0.00%
Nomior Score
72
Discounted QualityTop 8% of the scored universe
Growth—
Quality79
Value69
Momentum70
Resilience50
Growth
+67.21%revenue a year over 9 fiscal years
YE16 $712KYE25 $72.8M
Connections
Revenue to profitYE25
49% of revenue became net profit, up 100 pts on a year.
Who owns it
1tracked portfolio